Wellorithm review

On catalogue Wellorithm is a good fit for this site: compounded semaglutide and compounded tirzepatide are each offered as an oral dissolving tablet as well as an injection, and a tablet is a far more forgiving vehicle for a small dose than a part-filled syringe. Four branded pens and sermorelin sit alongside. The problem is that none of it carries a price. The pricing page returns a 404, every "Get Started" leads to a two-minute quiz, and the FAQ answers the cost question by describing what programmes generally do rather than what this one charges — which leaves the single question a microdoser is here to answer unanswerable. Two further claims on its own homepage do not hold up against the rest of the site: it advertises "Serving All 50 States" while its FAQ says 49 and excludes Louisiana, and the four people captioned "board-certified obesity specialists" are listed under Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery.

⚠ No price anywhere on the public site — the pricing page 404s and every product CTA leads to an intake quiz, so the one thing a microdoser needs to know (what a fraction of a dose costs) cannot be established before signing up

A telehealth weight-management platform with an unusually wide catalogue for this board — compounded semaglutide and tirzepatide each available as a weekly injection OR an oral dissolving tablet, four branded pens, and sermorelin. For a low-dose reader the ODT route is the draw: a tablet is a far more forgiving vehicle for a small dose than a syringe. What you cannot do is cost it. No price appears anywhere on the public site, the pricing page 404s, and every product link routes into a two-minute quiz. Two claims on its own homepage also fail against the rest of the site.

Pricing structure

Varies by dose, plan or tier

Consult

Included in the price

Compounding

Not publicly identified

Labs

Not required

Dietitian support

Not included

• Both molecules as oral dissolving tablets as well as injections — a needle-free route for each, which is rare here
• Four branded pens (Mounjaro, Ozempic, Wegovy, Zepbound) on the same account
• Sermorelin offered alongside the GLP-1 line
• 24/7 support on a published phone number

• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
• The site contradicts itself on coverage: the homepage says “Serving All 50 States” while its own FAQ says 49 states and excludes Louisiana
• The four clinicians presented as “board-certified obesity specialists” are captioned Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
• “100% Customer Satisfaction” is stated as a headline fact and is not substantiable

Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• Sublingual troches and drops
• Oral semaglutide (Rybelsus)
• Is compounded GLP-1 safe?
• Microdose & reconstitution calculator
• Pen click calculator

Wellorithm is one of 26 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.